Sponsored Content
SIVI is a standardized extract prepared using the aerial parts of Passiflora incarnata developed to enhance the quality of sleep. The objective of the present study was to the evaluate efficacy and safety of SIVI (Passiflora incarnata extract) in the management of stress and sleep problems in Indian participants in a randomized, double-blind, placebo-controlled, clinical study.
A total of 65 participants with stress and insomnia were randomized to two groups with 32 in the SIVI (Passiflora incarnata extract) group and 33 in the placebo group. Subjects were asked to take the test substance along with water at bedtime for 30 days. The Perceived Stress Scale, quality of life using the General Health Questionnaire (GHQ-12) scale, and Insomnia Severity Index were assessed on day 1, day 15, and day 30.
Passiflora incarnata extract showed a statistically significant reduction in the mean score of stress on the Perceived Stress Scale and significantly increased the mean score of total sleep time compared to placebo. The general psychological health was found to be significantly improved in the SIVI (Passiflora incarnata extract) group compared to the placebo group on day 15 and day 30. SIVI (Passiflora incarnata extract) did not show any adverse effects.
The results of the current study indicate that Passiflora incarnata extract is beneficial in the management of stress and helps to improve sleep quality in subjects with stress and insomnia.

23 Feb 2026
PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.
Read more
12 Feb 2026
Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.
Read more
22 Jan 2026
The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.
Read more
6 Jan 2026
HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...
Read more
22 Dec 2025
PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...
Read more
11 Dec 2025
Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...
Read more
11 Dec 2025
Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...
Read more
11 Dec 2025
Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...
Read more
4 Dec 2025
Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.
Read more
1 Dec 2025
Prayon inaugurates its new SHMP production unit in Engis, a major investment that strengthens its position in the food and technical phosphates market
Read more